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Available online 24 June 2011Reliable and simple methods are required for detection of low concentrations of cytokines and
some other proteins in complex biological fluids. This is especially important when monitoring
the immune responses under various physiological and pathophysiological conditions in vivo
or following production of these compounds in in vitro systems. Cytokines and other
immunologically active molecules are being predominantly detected by enzyme-linked
immunosorbent assays (ELISA) and newly also by immuno-polymerase chain reactions
(iPCR). New simpliﬁed variants of iPCR have recently been described where antibodies are
connected with multiple DNA templates through gold nanoparticles (Au-NPs) to form a new
class of detection reagents. In this study we compared functionalized Au-NP-based iPCR (Nano-
iPCR) with standard ELISA and iPCR for the detection of interleukin (IL)-3 and stem cell factor
(SCF). The same immunoreagents (IL-3- and SCF-speciﬁc polyclonal antibodies and their
biotinylated forms) were used throughout the assays. The obtained data indicate that both
Nano-iPCR and iPCR are superior in sensitivity and detection range than ELISA. Furthermore,
Nano-iPCR is easier to perform than the other two methods. Nano-iPCR was used for
monitoring changes in concentration of free SCF during growth of mast cells in SCF-conditioned
media. The results show that growing cultures gradually reduce the amount of SCF in
supernatant to 25% after 5 days. The combined data indicate that Nano-iPCR assays may be
preferable for rapid detection of low concentrations of cytokines in complex biological ﬂuids.
© 2011 Elsevier B.V. Open access under CC BY-NC-ND license.Keywords:
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Y-NC-ND license.important mediators of the immune system. Abnormal
activities of several cytokines, including interleukin (IL)-3,
have been reported in schizophrenia (Chen and Kendler,
2008), and elevated levels of stem cell factor (SCF) have been
detected in asthmatic patients (Lei et al., 2008). Sensitive,
simple and robust methods are required for diagnostic
purposes to determine low concentrations of cytokines in
complex biological ﬂuids. They are needed for monitoring
immune responses in vivo as well as for rapid analysis of the
quality of conditioned media used in culturing cytokine-
dependent cells. Growth of mouse bone marrow-derived
mast cells (BMMCs) in vitro, is promoted by two cytokines,
IL-3 and SCF (Tsuji et al., 1991). Concentrations of these and
other cytokines are being determined by several methods,
such as bioassays employing cytokine-dependent freshly
isolated cells or cell lines (Chen et al., 1993). Although very
useful, these assays are time consuming and inaccurate.
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enzyme-linked immunosorbent assays (ELISA) utilizing anti-
bodies speciﬁc for the target proteins (Silman and Katchalski,
1966; Engvall and Perlmann, 1971). However, the sensitivity
of these assays is not always sufﬁcient. It has been shown that
the amount of cytokine produced by cells correlates with the
expression of cytokine-speciﬁc mRNA; reverse-transcription
(RT) polymerase chain reactions (PCR) have therefore also been
widely used. Although RT-PCRs are fast, sensitive and simple
methods to detect the expression levels of cytokine genes, the
results do not always agree with those of bioassays and ELISA,
and do not allow exact determination of cytokine concentra-
tions. Other assays have therefore been explored. In 1992 a new
technique was described, combining molecular speciﬁcity of
antibodies with the ampliﬁcation power and sensitivity of PCR
(Sanoet al., 1992). In this technique, called immuno-PCR (iPCR),
theantibodyused for detection of target compound is combined
with the DNA which serves as a template in PCR. Different
strategies have been applied for linking antibodies with DNA
templates, like streptavidin bridge combined with biotinylated
antibody and biotinylated DNA template, or chemically conju-
gated antibody-DNA complexes (Lind and Kubista, 2005;
Niemeyer et al., 2007). The amount of DNA ampliﬁed during
PCR corresponds to the amount of target structure recognized
by the antibody, and can be detected by electrophoresis (Zhou
et al., 1993) or by ELISA, utilizing digoxigenin- or biotin-labeled
PCR products (Niemeyer et al., 1997; Smrž and Dráber, 2003).
Later, immunodetection was combined with real-time PCR and
used for quantiﬁcation of vascular endothelial grow factor
(Sims et al., 2000). The method was further modiﬁed in
such a way that both protein detection and real-time PCR
were performed in the same well of the TopYield strip
(Niemeyer et al., 2007). Furthermore, a gold nanoparticle
(Au-NP)-based bio-bar code assay for ultrasensitive detec-
tion of proteins has been developed. The assay utilizes Au-
NPs functionalized with both thiolated single-strand DNA
oligonucleotide and an antibody to the target antigen
(Nam et al., 2003, 2004; Georganopoulou et al., 2005).
Finally, PCR assays based on antibody- and oligonucleotide-
functionalized Au-NPs were used for detection of Hantaan
virus nucleocapsid protein (Chen et al., 2009) and respira-
tory syncytial viruses (Perez et al., 2011). Although the
assays showed high sensitivity for virus detection, they
required two sets of wells (for immunodetection and PCR)
and therefore were not suitable for high throughput
screening andwere fraught with high risk of contamination.
Here we tested the suitability of functionalized Au-NPs-
based iPCR (Nano-iPCR) for detection of low concentrations
of cytokines in cell culture supernatants, and changes in
cytokine concentration in aging cultures of BMMCs. We
deﬁned the conditions for simpliﬁed detection of cytokines
by Nano-iPCR, and compared the performance of assays
based on antibodies anchored either directly on the plastic
surface or through extravidin. The assays were carried out
in PCR polypropylene wells or wells of TopYield polycar-
bonate strips which allow more efﬁcient binding of
antibodies. We further compared Nano-iPCR with iPCR
and ELISA; outline of the assays is shown in Fig. 1. For these
comparisons we utilized identical immunoreagents in all
assays. The data indicate that Nano-iPCR offers a sensitive,
rapid and robust assay for detection of low concentrationsof cytokines in complex biological ﬂuids. Advantages and
drawbacks of different assays are discussed.2. Materials and methods
2.1. Materials
Rabbit anti-murine IL-3 and rabbit anti-murine SCF poly-
clonal antibodies and their biotinylated forms, recombinant (r)
murine IL-3 and rSCF were all obtained from PeproTech
(London, UK). Colloidal Au-NPs (30 nm), containing approxi-
mately 2×1011 Au-NPs/ml, were obtained from BBInterna-
tional (Cardiff, UK). Au-NPs (5 nm) conjugated with goat anti-
rabbit IgG were bought from Jackson ImmunoResearch Lab.,
Inc. (West Grove, PA, USA). 5′thiol-modiﬁed oligonucleotide
primer (Pri)1 [5′-(5ThioMC6-D//iSp18)CCTTGAACCTGTGCCAT
TTGAATATATTAAGACTATACGCGGGAACA-3′] where iSp18 is
an 18-atom hexa-ethyleneglycol spacer connecting the thiol
reactive group and the DNA sequence, Pri2 (5′-CCTTGAACCTGT
GCCATTTG-3′) and Pri3 (5′-GTCCCTCCATCTTCCTACTGTTCCA-
CATGTTCCCGCGTATAGTCTT-3′) were obtained from IDT, (Cor-
alville, IA,USA). Biotinylated forwardprimer5B-HRM1-F (5′-CT
CATCACCACGCTCCATTA-3′) and its non-biotinylated form
(HRM1-F) and reverse primer HRM1-R (5′-TCTTCCACCTCCAT
GGTGTC-3′) were obtained from Generi Biotech (Hradec
Králove, Czech Republic). SYTO-9 and geneticin (G418) were
obtained from Invitrogen (Eugene, OR, USA). Glutaraldehyde
was bought from Fluka, Chemie GmbH (Buchs, Switzerland).
All other chemicals were from Sigma-Aldrich (St. Louis, MO,
USA).2.2. Cells
BMMCs were isolated from C57BL/6 mice according to the
previously reported protocol (Volná et al., 2004). All mice
were maintained and used in accordance with the Institute of
Molecular Genetics guidelines. The cells were seeded in
complete culture medium RPMI-1640 containing 10% heat
inactivated (56 °C, 30 min) fetal bovine serum (FBS), 50 μM
2-mercaptoethanol, antibiotics (100 U/ml penicillin and
100 μg/ml streptomycin) and further supplemented with
fresh rSCF (15 ng/ml) and 10% culture supernatant of conﬂuent
D11 cells as a source of IL-3 (Cao et al., 2007). BMMCs were
culturedat37 °C inanatmosphereof 5%CO2 inair.D11cellswere
grown adherent in tissue culture ﬂasks in Dulbecco's modiﬁed
Eaglemedium(DMEM) supplementedwith 10%heat inactivated
FBS, antibiotics and 0.3 mg/ml of geneticin. The cells were
detached from the ﬂasks by incubation for 5–10 min at room
temperature with 0.05% trypsin in phosphate buffered saline
(PBS; 10 mM phosphate, pH 7.4, 150 mM NaCl) supplemented
with 0.02% EDTA. After centrifugation at 280 ×g for 5 min, cells
were resuspended inDMEM-10%FCSwithgeneticin. After 3 days
of culturing, the medium was aspirated and fresh DMEM
medium without geneticin was added. Cells were cultured for
additional week. Supernatant containing IL-3was then collected,
centrifuged at 5500 ×g for 15 min, ﬁltered through a 0.22 μm
membrane and stored in aliquotes at−20 °C. For determination
of SCF, supernatant from cultured BMMCswas collected daily for
5 days.
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Functionalized Au-NPs were prepared as previously de-
scribed (Hill and Mirkin, 2006) with some modiﬁcations. One
milliliter of 30 nmAu-NPs solution was incubated for 30 min at
room temperaturewith 4 μg of polyclonal antibody (anti-IL-3 or
anti-SCF) under gentle shaking. Tenmicroliters of 10%Tween20
was then added, followed after 5 min by 50 μl of 2 M NaCl in
10 mM PBS (Hurst et al., 2008). The particles were then
modiﬁed with 5′-thiolated oligonucleotide (ﬁnal concentration
4 nmol/ml) under gentle shaking at 4 °C. After overnight
incubation the samples were further salted by adding 50 μl
aliquotes of 2 MNaCl in 10 mMPBS in 4 subsequent steps, each
for 1 h. FunctionalizedAu-NPswere stabilized by adding20 μl of
10% bovine serum albumin (BSA), followed by gentle shaking
for 30 min at room temperature. Unbound oligonucleotides
were removed by three times centrifugation (9.300 ×g for
10 min) through a discontinuous glycerol gradient in 2 ml
Eppendorf tubes. The gradient consisted of 800 μl PBS contain-
ing 30% glycerol (w/v) and 1% BSA (w/v), overlaid with 1 ml of
functionalized Au-NPs. The pellet was ﬁnally resuspended in
1 ml of PBS containing1%BSA, 0.05%Tween20, 20%glycerol and
0.02% NaN3. In some experiments Au-NPs were functionalized
with BSA instead of antibody. Absorption spectrawere recorded
with a UV-1601 spectrophotometer (Shimadzu Corporation,
Kyoto, Japan) equipped with software package UVProbe
(Shimadzu) and quartz cells (200 μl) with 10 mm path length.
2.4. Electron microscopy
Nickel electron microscopy grids coated with pioloform
were glow discharged and coated with poly-L-lysine. Au-NPs
functionalized with antibodies or with BSA were allowed to
settle on the coated grids. After 10 min, the grids were washed
in PBS and free protein-binding sites were blocked for 15 min
with 0.1% BSA in PBS. Grids with bound Au-NPs were then
incubated with the secondary antibody (goat anti-rabbit IgG,
conjugated with 5 nm Au-NPs), diluted 1:10 in PBS-0.1% BSA.
After 30 min the grids were washed three times for 5 min each
with PBS. The gridswereﬁxed in 2.5% glutaraldehyde in PBS for
10 min. Finally, samples were washed twice with MilliQ water
(Millipore, Billerica, MA, USA) for 1 min, air-dried and
examined with a JEOL JEM-1200EX transmission electron
microscope (JEOL, Tokyo, Japan) operating at 60 kV.
2.5. Nano-iPCR
For detection of cytokines by Nano-iPCR, two methods
were used differing in the mode of anchoring the antibodies
to plastic surface. In Nano-iPCR I biotinylated antibody wasFig. 1. Schematic illustration of the immunoassays used in this study. In Nano-iPCR I
with extravidin (ExAv) to which biotinylated antigen-speciﬁc antibody (Ab-Bt) wa
added and bound to the immobilized antibody. The antibody anchored antigen was
oligonucleotide which served as a template in subsequent real-time PCR with a set
using DNA binding dye SYTO-9. In Nano-iPCR II method, the antibody (Ab) was b
binding sites with BSA; all other steps were the same as in Nano-iPCR I. In iPCR and
well, followed by BSA block. Antigen was then added and detected by biotinylate
biotinylated antibody and biotinylated DNA template (DNA-Bt) added during the n
template-speciﬁc primers), and the amplicons were detected by means of SYTO-9
streptavidin-HRP conjugate (S-HRP). The enzymatic activity was detected using a co
quantiﬁed by spectrophotometery.attached to immobilized extravidin, whereas in Nano-iPCR II
the antibody was directly bound to the plate.
2.5.1. Nano-iPCR I
One hundred microliter aliquotes of extravidin (1–2 μg/ml
in 100 mM borate buffer, pH 9.5) were added into each well of
real-time 96-well plate or real-time tube strip (Eppendorf,
Hamburg, Germany) and incubated for 1 h at 37 °C. After
adsorption of the protein, the wells were washed with PBS
containing 0.05% Tween 20 (TPBS) and the remaining binding
sites were blocked by 2 h incubation at 37 °C with TPBS
supplementedwith 2% BSA. The wells were then washed three
times with 200 μl of TPBS, followed by addition of 100 μl
biotinylated anti-SCF or anti-IL-3 antibody (1 μg/ml in TPBS-1%
BSA). After incubation for 1 h at 37 °C, unbound antibody was
rinsed out and 100 μl sample aliquotes were probed for the
presence of SCF or IL-3. The samples were incubated overnight
at 4 °C, and after washing four times with TPBS, 100 μl of
Au-NPs armedwith thiolatedDNAoligonucleotide andanti-SCF
or anti-IL-3 (diluted 1/10,000 in TPBS-1% BSA) were applied
into each well. The wells were incubated for 1 h at 37 °C,
washed 4 times with 200 μl TPBS followed by double washing
with MilliQ water. Next, aliquotes of 25 μl of master mix
solution containing 75 mM Tris–HCl (pH 8.8), 20 mM
(NH4)2SO4, 2.5 mM MgCl2, 200 μM dATP, 200 μM dGTP,
200 μM dCTP, 200 μM dTTP, Taq DNA polymerase (25 U/ml),
2 μM SYTO-9 and 60 nM oligonucleotide primers Pri2 and Pri3
were dispensed into each well. Plates were sealed with Light
cycler 480 sealing foil (Roche, Mannheim, Germany) and PCR
strips with Masterclear cap strips (Eppendorf). The amount of
template DNA bound to antigen-anchored functionalized
Au-NPs was evaluated by real-time PCR using Realplex4
Mastercycler (Eppendorf, Hamburg, Germany) with the
following cycling conditions: 1 min at 94 °C, followed by 40
cycles of 20 s at 94 °C, 20 s at 53 °C and20 s at 72 °C. The control
without template DNA was used for PCR mix in every run to
check for contamination.
2.5.2. Nano-iPCR II
Twenty-ﬁvemicroliter aliquotes of capture antibody (5 μg/ml
anti-IL-3 or anti-SCF; Peprotech) in 100 mM borate buffer (pH
9.5) were distributed into each well of TopYield strips (NUNC,
Roskilde, Denmark). After 1 h incubation at 37 °C and overnight
incubationat 4 °Ceachwellwaswashed four timeswith200 μl of
TPBS, and free binding sites were blocked with TPBS-2% BSA for
2 h at 37 °C. Each well was washed four times with TPBS,
followed by addition of 25 μl of the tested sample containing IL-3
or SCF and incubation for 1 h at 37 °C. Other stepswere the same
as in Nano-iPCR I. Cycling conditions were as follows: 2 min at
95 °C, 40 cycles of 15 s at 95 °C, 60 s at 60 °C and 60 s at 72 °C.method, wells of real-time 96-well plate or real-time tube strips were coated
s anchored. BSA was used to block free binding sites. Antigen (Ag) was then
detected by Au-NPs functionalized by antigen-speciﬁc antibody and thiolated
of template-speciﬁc primers. DNA amplicons were detected by ﬂuorometry
ound directly to the TopYield strip wells followed by blocking free protein-
ELISA, the Ag-speciﬁc antibody was adsorbed directly onto the surface of the
d antibody. In iPCR, extravidin was supplied to form a bridge between the
ext step. Template DNA was then ampliﬁed by real-time PCR (using a set of
DNA dye. In ELISA, biotinylated antibody immobilized on Ag reacted with
lorimetric reaction with OPD as a substrate. The colored end-product (P) was
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The method was performed as previously described
(Niemeyer et al., 2007) with some modiﬁcations. Biotinylated
DNA template (221 bps) was obtained by PCR using biotiny-
lated forward primer 5B-HRM1-F (200 nM), reverse primer
HRM1-R (800 nM) and ampliﬁed template DNA (0.1 ng;
GenBank accession no. M14752). The following cycling condi-
tionswere used: 2 min at 95 °C, followed by 30 cycles of 15 s at
95 °C, 30 s at 58 °C and 20 s at 72 °C. Each well of the TopYield
strip contained 25 μl polyclonal antibody speciﬁc for IL-3 or SCF
(5 μg/ml, in 100 mM borate buffer pH 9.5). The wells were
incubated for 1 h at 37 °C and overnight at 4 °C, followed by
washing four timeswith 200 μl of TPBS. Free binding sites were
blocked by incubation with TPBS-2% BSA. After 2 h at 37 °C, the
wells were again washed four times and overlaid with 25 μl of
tested samples containing various concentrations of IL-3 or SCF.
Thewellswere further incubated for 1 h 37 °C and thenwashed
4 timeswith TPBS. Subsequently, 25 μl aliquotes of biotinylated
antibody speciﬁc for IL-3 or SCF (1 μg/ml in TPBS-1% BSA)were
dispensed and the samples were incubated for 1 h at 37 °C.
After washing four times, the wells were covered with 25 μl of
extravidin (0.1 μg/ml) in TPBS-1% BSA, incubated for 1 h at
37 °C and washed as before. After this step, biotinylated DNA
template (25 μl; 0.27 pg/ml) was added and the strips were
incubated for 1 h at 37 °C. Next, the wells were washed four
times with TPBS and twice with MilliQ water. The amount of
biotinylatedDNA template immobilized in individualwellswas
quantiﬁed by real-time PCR using master mix supplemented
with HRM1-F and HRM1-R primer set (200 nM each). The
following cycling conditions were used: 2 min at 95 °C as an
initial denaturation step and 40 cycles consisting of 15 s at
95 °C, 60 s at 60 °C and elongation for 60 s at 72 °C.
2.7. ELISA
ELISA was performed as previously described (Engvall and
Perlmann, 1971) with some modiﬁcations. Wells of the
TopYield strips were coated with Ag-speciﬁc polyclonal
antibody, blocked with TPBS-2% BSA and then mixed with
antigen as described above for iPCR. The wells were then
washed three times with TPBS, followed by addition of 100 μl
biotinylated antibody (1 μg/ml, in TPBS-1% BSA), incubation for
1 h at 37 °C and washing three times with TPBS. One hundred
microliters of streptavidin-horseradish peroxidase (HRP) con-
jugate (0.1 μg/ml) was then added. After incubation for 1 h at
37 °C the wells were washed three times with TPBS. Finally,
100 μl PBS containing o-phenylenediamine (OPD; 0.5 mg/ml)
and H2O2 (0.015%) was dispensed into each well. After 10 min
at 37 °C, the reaction was stopped by adding 100 μl of H2SO4
(4 M). The absorbancewasdetermined at492 nmusing Inﬁnite
M200 plate reader (TECAN, Männedorf, Switzerland).
2.8. Data analysis
For calibration curves, absorbance or quantiﬁcation cycle
(Cq) valueswereplottedagainst SCFor IL-3 concentrationsusing
a four-parameter logistic regression model function (variable
slope) within GrafPad Prism 5 (GraphPad Software, La Jolla, CA,
USA). For calculation of IL-3 or SCF concentrations in the tested
samples, the same mathematical model was used, usingMasterPlex ReaderFit software (Hitachi Solutions America, Ltd,
MiraiBio Group, South San Francisco, CA, USA).
3. Results
3.1. Characterization of functionalized Au-NPs
Au-NPs functionalized with thiolated oligonucleotides and
antibodies were initially characterized by two methods. The
presence of antibodies bound to 30 nm Au-NPs was veriﬁed by
means of secondary anti-immunoglobulin-speciﬁc antibodies
conjugated to 5 nm Au-NPs. Formation of rosettes of 30 nm
Au-NPs surrounded by 5 nm-Au-NPs detectable by electron
microscopy was taken as an evidence of the presence of
antibodies on 30 nm Au-NPs. As shown in Fig. 2A, all 30 nm
Au-NPs formed rosettes with 5 nm particles. The binding was
speciﬁc as indicated by the absence of rosettes in samples
containing30 nmAu-NPs coveredwithBSA insteadof antibodies
(Fig. 2B) orwith thiolated oligonucleotides alone (not shown). A
typical distributionpattern of 30 nmAu-NPs associatedwith 1–7
gold5 nmparticles is shown inFig. 2C. It shouldbenoted that the
number of 5 nm particles bound to 30 nm Au-NPs is under-
estimated because a fraction of 5 nm particles is overshadowed
by the dense bodies of 30 nm particles.
Concentrations and physical properties of functionalized
Au-NPs were characterized by means of UV–vis spectropho-
tometry (Fig. 2D). Unconjugated 30 nm Au-NPs showed an
absorption peak at 525 nm. This changed to higher wavelength
values by 5–10 nm if the particles were functionalized by
antibodies and oligonucleotides. Absorption maxima at values
N535 nm were indicative of suboptimal performance of the
particles in Nano-iPCR. The actual values of the 525–535 nm
peak and calculated extinction coefﬁcient [ε528 nm=3.7 x
109 cm−1 M−1 (Jin et al., 2003)]made it possible to determine
the number of particles present in the sample.
The number of single-stranded oligonucleotides bound
to 30 nm Au-NPs was evaluated by a modiﬁed real-time PCR-
basedmethod (Kim et al., 2006)where DNA binding dye SYTO-
9was used instead of a ﬂuorescence probe. Au-NPswith bound
thiolated Pri1 oligonucleotide were directly diluted into SYTO-
9-containing PCRmastermix supplementedwith primers (Pri2
and Pri3), and analyzed by real-time PCR (Fig. 3A). Linearity of
the data and regression coefﬁcients close to 1 indicated that the
presence of 30 nm Au-NPs did not interfere with the assay and
therefore was not necessary to dissociate oligonucleotide
template from Au-NPs before the PCR. Similar good linearity
and reasonable regression coefﬁcients were observed in assays
containing a deﬁned amount of free Pri1 oligonucleotide
(Fig. 3B). Based on the results of such assays and estimated
numberof goldparticles in stock solutionsof functionalizedAu-
NPs it was possible to calculate the number of oligonucleotides
per one oligonucleotide- and antibody-functionalized particle
as 83±26 (mean±S.D.; n=5). The 1/104 dilution of functio-
nalized Au-NPs in Nano-PCR assays corresponds to approxi-
mately 1.4 pmol/l of Pri1 oligonucleotide.
3.2. Optimization of the Nano-iPCR
The sensitivity of immunoassays is limited by background
signal caused by nonspeciﬁc binding of assay components (pri-
mary and secondary antibodies, antigen, extravidin, biotinylated
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Fig. 2. Characterization of antibody-functionalized Au-NPs. (A, B) Electron microscopy visualization of polyclonal antibody bound to Au-NPs. (A) 30 nm Au-NPs
were conjugated with polyclonal antibody followed by an exposure to secondary 5 nm Au-NP labeled with anti-IgG. After washing the particles were observed by
electron microscopy. (B) Control 30 nm Au-NPs were conjugated with BSA, followed by an exposure to 5 nm Au-NP-labeled anti-IgG antibody. (C) Distribution of
5 nm Au-NPs (armed with anti-rabbit IgG) bound to 30 nm Au-NPs functionalized with polyclonal rabbit antibody. In total, 84 particles of 30 nm size were
evaluated. (D) UV–vis spectrophotometry of control (Au-NP) and oligonucleotide- and antibody-functionalized particles (F-Au-NP).
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other and plastic surfaces of the wells. In pilot experiments we
therefore tried to deﬁne the optimal conditions for iPCR. We
compared the performance of two buffers (PBS or HEPES)
supplemented with several blocking agents at different concen-
trations (2–5% BSA, 2% ovalbumin or 2% casein) and twoBA
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10
15
20
25
30
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Fig. 3. Characterization of oligonucleotide-functionalized Au-NPs. (A) Real-time
oligonucleotide. (B) Real-time PCR detection of various concentrations of oligonucle
from 3 independent experiments performed in triplicates.differentdetergents at various concentrations (0.01–0.2%Tween
20 or 0.1–2% Pluronic F68). A series of optimization experiments
showed that themost effective agents for blocking andwashing
were TPBS-2% BSA and TPBS, respectively.
In initial experiments with TopYield strips we noticed, in
accordance with previous studies (Barletta et al., 2004, 2005;10
15
20
25
30
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PCR performance of various dilutions of Au-NPs functionalized with Pri1
otide Pri1 alone. Correlation coefﬁcients (R), means and S.D. were calculated
44 L. Potůčková et al. / Journal of Immunological Methods 371 (2011) 38–47Barletta, 2006) that there is a relatively high variability in the
results and poor sensitivity. One possible cause was inferior
heat transfer in wells of the TopYield strips during PCR. This
was solved by extending the synthesis phase of the PCR
cycles. Another problem was that larger surface area caused
higher evaporation of PCR mixes, even though the wells were
sealed with light cycler 480 sealing foil. We therefore added
5 μl of mineral oil into each well before they were sealed.
Mineral oil prevented evaporation and improved the perfor-
mance of detection of various concentrations of rIL-3 (Fig. 4)
and rSCF (not shown).
3.3. Comparison of various immunoassays
To compare various immunoassays for detecting cytokines,
we tested theperformance ofNano-iPCR I and II, iPCRandELISA
for detection of rIL-3 and rSCF at various concentrations. For
IL-3, polypropylenewells of the 96-well PCR plate (Eppendorf)
were coated with extravidin, followed by anti-IL-3 polyclonal
antibody (Nano-iPCR I). Alternatively, wells of TopYield
strips (NUNC) were coated directly with anti-IL-3 antibody
(Nano-iPCR II, iPCR and ELISA). Next, free binding sites were
blocked with TPBS-2% BSA and rIL-3 at various concentrations
was added. After incubation, unbound IL-3 was removed by
washing with TPBS. Further course of the procedures differed
depending on the method used (see Section 2 and Fig. 1).
Analysis of data obtained showed that Nano-iPCR I (Fig. 5A)
exhibited clear concentration-dependent differences in the
range of 0.01–100 ng/ml of IL-3 with Cq values from ~35 (at
100 ng/ml) to ~46 (at 0.01 ng/ml). These relatively high values
probably reﬂect low protein binding capacity of PCR polypro-
pylenewells.Nano-iPCR II (Fig. 5C)performed inpolycarbonate
TopYiled strips showed lower Cq values in the range from ~19
(at 100 ng/ml) to ~32 (at 0.01 ng/ml). With iPCR (Fig. 5E), the
dose–response curve was similar to that of Nano-iPCR II assay,
except for even lowerCq values, from~15(at 100 ng/ml) to ~24
(at 0.01 ng/ml). This was in part caused by lower Cq values
in negative controls (without IL-3) in iPCR compared to Nano-
iPCR, and could be related to higher nonspeciﬁc binding of the
biotinylated template used for iPCR. In contrast to Nano-iPCR
and iPCR, ELISA assay (Fig. 5G)was less sensitive and the range
of IL-3 concentrations detectable by the assay was narrower0.1 1 10 100
14
16
18
20
+ Oil
- Oil
IL-3 (ng/ml)
C q
Fig. 4. The effect of mineral oil overlay on iPCR detection of IL-3 in wells o
TopYield strips. Various concentrations of IL-3 were detected by iPCR in wells
of TopYield strips overlaid (+) or not (−) with 5 μl of light mineral oil and
sealed with real-time PCR transparent foil. Means and S.D. were calculated
from 3 independent experiments performed in triplicates.f(between 0.1 and 10 ng/ml).
Similar data were obtained when various assays were
used for detection of rSCF. Thus, Nano-iPCR I (Fig. 5B),
compared to Nano-iPCR II (Fig. 5D) and iPCR (Fig. 5F), was
characterized by relatively high Cq values (including negative
controls without rSCF) and higher sensitivity at low concen-
tration of rSCF. ELISA assay (Fig. 5H) was again less sensitive,
and also the range of rSCF concentrations detectable by the
assay was reduced (0.1–10 ng/ml). The data indicate that
Nano-iPCRs and iPCRs are superior in sensitivity and exhibit
broader range of detectable concentrations than ELISA.
3.4. Cytokine detection in cell culture supernatants
To prove the convenience of Nano-iPCR we attempted to
determine changes in the amount of rSCF during growth of
BMMCs in RPMI-1640medium supplemented with 10% FCS and
SCF. Cell-free samples from cell cultures were collected at 24 h
intervals for 5 days. In parallel, samples were also collected from
cultures containing medium alone to determine the rate of
degradationofSCFduring incubatedat37 °C.Data in Fig. 6Ashow
that growing cells gradually deplete the amount of rSCF. At the
beginning of the experiment, samples contained SCF at concen-
tration 15 ng/ml, but after 5 days, only about 3.7 ng SCF/ml
remained (75% reduction). Similar data were obtained with
ELISA. Degradation of rSCF in cell-free culture media had little
effect, since the slight decrease there (9.5%) was only observed
after 24 h of incubation and then remained constant. Binding of
rSCF to the plasma membrane receptor (c-kit) and its internal-
ization and subsequent degradation seems to be main cause of
the observed depletion of rSCF from culture medium.
Next, we compared the efﬁciencies of various immunoas-
says for detection of IL-3 released into culture supernatant by
growing D11 ﬁbroblasts. Concentration of IL-3 was determined
by Nano-iPCR II, iPCR and ELISA. Data presented in Fig. 6B
indicate that D11 supernatant diluted 1:16 with TPBS-1% BSA
contained 21.6±2.0 ng/ml IL-3 (mean±S.D.; n=3), corre-
sponding to 346±32 ng/ml of undiluted supernatant. Higher
dilutions of the supernatant had no effect on calculated
concentration of IL-3. Similar data were obtained with iPCR
(359±90 ng/ml) or ELISA (384±58 ng/ml).
4. Discussion
We compared three different immunoassays (Nano-iPCR,
iPCR and ELISA) for detection of low concentrations of cytokines.
Nano-iPCR was used in two formats differing in the mode how
the antigen-speciﬁc antibodies were anchored to the reaction
wells. In Nano-iPCR I, biotinylated antibody was anchored to
immobilized extravidin, whereas in Nano-iPCR II the antibody
wasbounddirectly to theplastic surface. Bothmodiﬁcationsused
Au-NPs functionalizedwith single-strandedoligonucleotides and
polyclonal antibodies speciﬁc for the cytokine in question. The
assays gave reasonable concentration-dependent Cq values,
although Nano-iPCR II showed higher nonspeciﬁc binding
reﬂected by lower Cq values even in the absence of antigen. The
components of the critical importance and limiting factors in all
immunoassays are the antibodies, since they can differ in
speciﬁcity and afﬁnity for the target antigen, as well as
nonspeciﬁc binding to the solid phase (McKie et al., 2002; Lind
and Kubista, 2005; Niemeyer et al., 2007). It is therefore essential
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Fig. 5. Detection of various concentrations of rIL-3 and rSCF in particular immunoassays. Nano-iPCR I (A and B), Nano-iPCR II (C and D), iPCR (E and F) and ELISA (G
and H) were used for detection of various concentrations of rIL-3 (A, C, E, G) or rSCF (B, D, F, H) in TPBS-1% BSA. Results are means±S.D. from 3 to 6 independent
experiment performed in triplicates or duplicates.
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speciﬁc for IL-3 or SCF. The observed differences are thus
attributable to the characteristics of the assays rather than
antibodies.
The particular assays differed in a number of features which
are summarized in Table 1. First, Nano-iPCR assays utilize
functionalized Au-NPs. Production of such particles possessing
both antibody and single-stranded oligonucleotides is more
time consuming than preparation of biotinylated antibodies for
ELISA and iPCR, or biotinylated double stranded oligonucleo-
tides for iPCR. On the other hand, preparation of Au-NP
conjugates is substantially easier than direct conjugation of
antibodies with oligonucleotide templates (Lind and Kubista,
2005). As shown in this study, bindingof theantibody toAu-NPs
can be quantiﬁed by electron microscopy. The analysis proved
that almost all Au-NPs bound several antibody molecules. The
number of oligonucleotides bound to a particlewas determined
by real-time PCR using functionalized Au-NPs diluted directly
into PCR mixes. Interestingly, even though each functionalized
Au-NP possessed in average 80 oligonucleotides, performance
of Nano-iPCR was comparable to the detection range of iPCR.
This can be related to a higher background reﬂected in lower Cq
values in iPCR calibration curves, including negative controls.
Second, an important parameter of immunoassays is the
type of wells or tubes in which the assays are performed. An
extensive array of various tubes, strips and plates ﬁtting to
different real-time PCR cyclers is available for PCR. However,
these tubes and wells are often made of polypropylene and
therefore exhibit a relatively low protein-binding capacity. At
present, only the TopYield polycarbonate strips have antibody
binding capacity comparable to polystyrene strips or plates
widely used for ELISA, and have a shape compatible with
heating blocks of various PCR cyclers. Our initial experiments
showed that real-time PCR performance of TopYield strips was
poor even in cyclers with heated lid. This was however
improved by changing the cycling conditions and covering
PCR master mixes with mineral oil. This obviously reduced
evaporation fromrelatively large surface area of TopYieldwells.
Third, both Nano-iPCR and iPCR detected the antigen with
higher sensitivity than ELISA. This reﬂects the ability of PCR to0 24 48 72 96 120
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Fig. 6. Determination of SCF and IL-3 in culture media used for growth of BMMCs. (A
The cells (1.0×106/ml) were cultured in complete RPMI-1640 medium supplement
intervals for 120 h. The amount of rSCF was determined with Nano-iPCR I (circles)
control, supernatants from cell-free cultures were also analyzed in parallel by ELISA
Supernatant was diluted 16-fold, 32-fold or 64-fold in TPBS-1% BSA and the amount
curves. Means and S.D. were calculated from 3 independent experiments.amplify even a very small number of template DNA molecules.
Initial studies indeed demonstrated a dramatic enhancement
(approximately ﬁve orders of magnitude) in detection sensi-
tivity when iPCR was used instead of ELISA (Sano et al., 1992).
However, these assays were performed under optimal condi-
tions where antigen (BSA) was directly immobilized to wells
and a potent monoclonal antibody speciﬁc for BSA was
available. When the antigen is present in a complex protein
mix, such as in serum-containing culture medium or in crude
body ﬂuids, and analyzed in a sandwich assay, Nano-iPCR and
iPCR usually detect the antigen with 1–3 orders higher
sensitivity than ELISA (Adler et al., 2003; Lind and Kubista,
2005; Chen et al., 2009; Perez et al., 2011). In a study aimed at
detecting mumps-speciﬁc IgG in serum samples, sensitivity of
the iPCR did not exceed that of conventional ELISA. It should be
kept in mind that Nano-iPCR and iPCR assays are substantially
less sensitive for quantiﬁcation of antigenic molecules when
compared to real-timePCR for quantiﬁcation of DNA templates.
This is attributable to high speciﬁcity of PCR and zero
ampliﬁcation in the absence of DNA template.
Fourth, another important factor is thevariabilityof theassays
and the rangeof detectable concentrations of antigen. It is known
that real-time PCR gives exponential signal ampliﬁcation and
real-timedetection.Underoptimal conditions (100%efﬁciency) a
10-fold increase in the amount of DNA template is associated
with a decrease in Cq value by a factor of 3.4. IPCR-based assays
are therefore especially useful for detection of target antigens at
large quantitative differences. In contrast, standard ELISA gives
linear signal ampliﬁcationandendpointdetectionand, therefore,
suits better for detection of smaller differences at lower range of
concentrations; meaningful calibration curves for ELISA span
usually two orders of magnitude or less.
Fifth, the labor requirement of the assaysmust also be taken
into consideration. As shown in Fig. 1, Nano-iPCR based assays
are less laborious because they have fever steps than iPCR or
ELISA. Once the probes (functionalized Au-NPs) are prepared
they can be stored for severalmonths and used immediately for
easy quantiﬁcation of the antigen.
Our primary intention was to develop an assay for detection
of cytokines in serum-supplemented cell culture media. Nano-6.25 3.12 1.56
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) Changes in concentration of rSCF in culture mediumwith the length of time
ed with 15 ng/ml rSCF (0 h). Cell culture supernatants were collected at 24-h
or ELISA (squares) using the corresponding calibration curves. As a positive
(triangles). (B) Quantiﬁcation of IL-3 in supernatant from cultured D11 cells
of IL-3 was determined with Nano-iPCR II using the corresponding calibration.
.
Table 1
Comparison of the immunoassays used.
Parameter Nano-iPCR iPCR ELISA
Reagents preparation + ++ ++
Tolerance for matrix + ++ ++
Sensitivity +++ +++ ++
Quantiﬁcation range +++ +++ +
Linearity +++ +++ ++
Variability ++ ++ +++
Robustness ++ ++ +++
Assay time +++ + ++
+++, the best attribute; ++, the medium attribute; +, the worst attribute.
47L. Potůčková et al. / Journal of Immunological Methods 371 (2011) 38–47iPCR performed in TopYield strips with master mixes covered
with oilﬁlmand transparent foil offers a simple and robust assay
for rapid detection of IL-3 and SCF using commercially available
antibodies and their biotinylated forms. The binding of antibody
and thiolated oligonucleotide template to Au-NPs is an easy
method of how to combine antibodies and oligonucleotides into
a complex suitable for the assays. The assay can be used for
quantiﬁcation of other ligands, provided good monoclonal or
polyclonal antibodies and their biotinylated forms are available.
In conclusion, Nano-iPCR assay shows enhanced sensitivity
and wider dynamic range than ELISA and is easier to perform
than iPCR. It can be expected that further improvement of the
Nano-iPCR assays, namely introduction of better detection
probes with higher ligand speciﬁcity and lower nonspeciﬁc
binding will advance the application of these tests for routine
detection of cytokines as well as other ligands. Synthetically
prepared tailoredDNAor RNAaptamers (Jayasena, 1999; Khati,
2010) and tailored recombinant binding proteins (Binz et al.,
2005) could provide such probes.
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